Scholarlink

Background <p>Data on quality-of-care indicators for breast cancer patients is limited in low—and middle-income countries. We evaluated the indicators in Iran.</p> Method <p>A total of 21 quality-of-care indicators of breast cancer management defined by EUSOMA 2017 were selected. The indicators were retrospectively evaluated based on the data from the Clinical Breast Cancer Registry established in 11 provinces of Iran.</p> Result <p>In the study of 6,293 patients evaluated on 21 indicators, 15 indicators were more than 5% below EUSOMA's standard levels.</p> Conclusion <p>The defined indicators had a value lower than the suggested standards by EUSOMA. This study's results highlight important clues for intervention in improving breast cancer outcomes in Iran and other low—and middle-income countries.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Evaluating the breast cancer quality of care indicators in Iran; multicenter study

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年5月23日

查看全文
  • Mojtaba Vand Rajabpour,
  • Monireh Sadat Seyyedsalehi,
  • Azin Nahvijou,
  • Saeed Nemati,
  • Shaghayegh Haghjooy Javanmard,
  • Amirreza Manteghinejad,
  • Sepideh Abdi,
  • Borna Farazmand,
  • Habibollah Pirnejad,
  • Arash Golpazir Sorkheh,
  • Jamshid Anasari,
  • Masoud Bahrami,
  • Maryam Marzban,
  • Seyedeh Masoumeh Ghoreishi,
  • Yahya Baharvand Iran Nia,
  • Fataneh Bakhshi,
  • Alireza Ansari-Moghaddam,
  • Maryam Moradi Binabaj,
  • Hassan Nourmohammadi,
  • Ramesh Omranipour,
  • Alireza Abdollahi,
  • Mahdi Aghili,
  • Mohammad Ali Mohagheghi,
  • Ali Ghanbari-Motlagh,
  • Partha Basu,
  • Paolo Boffetta,
  • Kazem Zendehdel

摘要

Background

Data on quality-of-care indicators for breast cancer patients is limited in low—and middle-income countries. We evaluated the indicators in Iran.

Method

A total of 21 quality-of-care indicators of breast cancer management defined by EUSOMA 2017 were selected. The indicators were retrospectively evaluated based on the data from the Clinical Breast Cancer Registry established in 11 provinces of Iran.

Result

In the study of 6,293 patients evaluated on 21 indicators, 15 indicators were more than 5% below EUSOMA's standard levels.

Conclusion

The defined indicators had a value lower than the suggested standards by EUSOMA. This study's results highlight important clues for intervention in improving breast cancer outcomes in Iran and other low—and middle-income countries.